FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Biotech Venture Capital Monitor – USA 11/2020”.
The Monitor is a monthly published overview of venture capital trends in the US-Biotech sector.
As of the end of November 2020, we identify the following current VC trends in the US-Biotech sector:
- In November 2020 the investment volume in the US-Biotech sector amounted to USD 1,655m
- In 2020, overall Biotech funding in the USA has reached USD 20,570m so far
- Top 5 deals exceed USD 300m each, largest transaction amounted to USD 493m in Lyell Immunopharma, Inc.
To access the full report, please click here.